{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2023:MMCY6EBBOC5TMC3PQP4QHOHKG4","short_pith_number":"pith:MMCY6EBB","canonical_record":{"source":{"id":"2302.09612","kind":"arxiv","version":2},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2023-02-19T16:16:33Z","cross_cats_sorted":["stat.AP"],"title_canon_sha256":"c5c74875966c306a7687d5a2d6d226132b244da62a4ead993029a12e64e8804d","abstract_canon_sha256":"7408f3f0fd3bfda391cb9e9d861c97242d01167706b9701e459a46ce8d4c6c8f"},"schema_version":"1.0"},"canonical_sha256":"63058f102170bb360b6f83f903b8ea3711c8f185c768d53476154a3713a44665","source":{"kind":"arxiv","id":"2302.09612","version":2},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2302.09612","created_at":"2026-07-05T06:46:00Z"},{"alias_kind":"arxiv_version","alias_value":"2302.09612v2","created_at":"2026-07-05T06:46:00Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2302.09612","created_at":"2026-07-05T06:46:00Z"},{"alias_kind":"pith_short_12","alias_value":"MMCY6EBBOC5T","created_at":"2026-07-05T06:46:00Z"},{"alias_kind":"pith_short_16","alias_value":"MMCY6EBBOC5TMC3P","created_at":"2026-07-05T06:46:00Z"},{"alias_kind":"pith_short_8","alias_value":"MMCY6EBB","created_at":"2026-07-05T06:46:00Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2023:MMCY6EBBOC5TMC3PQP4QHOHKG4","target":"record","payload":{"canonical_record":{"source":{"id":"2302.09612","kind":"arxiv","version":2},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2023-02-19T16:16:33Z","cross_cats_sorted":["stat.AP"],"title_canon_sha256":"c5c74875966c306a7687d5a2d6d226132b244da62a4ead993029a12e64e8804d","abstract_canon_sha256":"7408f3f0fd3bfda391cb9e9d861c97242d01167706b9701e459a46ce8d4c6c8f"},"schema_version":"1.0"},"canonical_sha256":"63058f102170bb360b6f83f903b8ea3711c8f185c768d53476154a3713a44665","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T06:46:00.721935Z","signature_b64":"SyTREL2qX1Db0sYWAaSTfR0MqKKNH6AEngdqm+2lkYlKxGt4Pa/S+01mF5L0LYiWxE7aPX8BBRZBHMAe01+UBQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"63058f102170bb360b6f83f903b8ea3711c8f185c768d53476154a3713a44665","last_reissued_at":"2026-07-05T06:46:00.721425Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T06:46:00.721425Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2302.09612","source_version":2,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T06:46:00Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"jodVQt4ILaBWyuHN61c7yAwOHHnDHuDkq1dCdiWre556g2/BG9YxYVG4QukH8KUXjgXaX7a8auIZ+07f1RA9AA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-13T15:21:26.641655Z"},"content_sha256":"76ab9c9ea6c3785c2b3d6df033b6577550bc00b90352e791e4916a4adf65453f","schema_version":"1.0","event_id":"sha256:76ab9c9ea6c3785c2b3d6df033b6577550bc00b90352e791e4916a4adf65453f"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2023:MMCY6EBBOC5TMC3PQP4QHOHKG4","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Design and Sample Size Determination for Multiple-dose Randomized Phase II Trials for Dose Optimization","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","headline":"","cross_cats":["stat.AP"],"primary_cat":"stat.ME","authors_text":"Bo Huang, Daniel Li, Peng Yang, Ruitao Lin, Ying Yuan","submitted_at":"2023-02-19T16:16:33Z","abstract_excerpt":"The conventional more-is-better dose selection paradigm, which targets the maximum tolerated dose (MTD), is not suitable for the development of targeted therapies and immunotherapies as the efficacy of these novel therapies may not increase with the dose. The U.S. Food and Drug Administration (FDA) has launched Project Optimus \"to reform the dose optimization and dose selection paradigm in oncology drug development\", and recently published a draft guidance on dose optimization, which outlines various approaches to achieve this goal. One highlighted approach involves conducting a randomized pha"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2302.09612","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2302.09612/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T06:46:00Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"rbKgvRUCo1TV4bv5f91nUKUReppyCVYSVKVm0o/RsQMPT1omV6QsqdhzCL7hUkFTblt8hoZKyKpdTAd51GXYCw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-13T15:21:26.642592Z"},"content_sha256":"d88403012f7cb9579a108cd77e6580ff7d86eee67584e8fa8c9e4a30afc9dc8c","schema_version":"1.0","event_id":"sha256:d88403012f7cb9579a108cd77e6580ff7d86eee67584e8fa8c9e4a30afc9dc8c"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/MMCY6EBBOC5TMC3PQP4QHOHKG4/bundle.json","state_url":"https://pith.science/pith/MMCY6EBBOC5TMC3PQP4QHOHKG4/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/MMCY6EBBOC5TMC3PQP4QHOHKG4/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-08-13T15:21:26Z","links":{"resolver":"https://pith.science/pith/MMCY6EBBOC5TMC3PQP4QHOHKG4","bundle":"https://pith.science/pith/MMCY6EBBOC5TMC3PQP4QHOHKG4/bundle.json","state":"https://pith.science/pith/MMCY6EBBOC5TMC3PQP4QHOHKG4/state.json","well_known_bundle":"https://pith.science/.well-known/pith/MMCY6EBBOC5TMC3PQP4QHOHKG4/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2023:MMCY6EBBOC5TMC3PQP4QHOHKG4","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"7408f3f0fd3bfda391cb9e9d861c97242d01167706b9701e459a46ce8d4c6c8f","cross_cats_sorted":["stat.AP"],"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2023-02-19T16:16:33Z","title_canon_sha256":"c5c74875966c306a7687d5a2d6d226132b244da62a4ead993029a12e64e8804d"},"schema_version":"1.0","source":{"id":"2302.09612","kind":"arxiv","version":2}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2302.09612","created_at":"2026-07-05T06:46:00Z"},{"alias_kind":"arxiv_version","alias_value":"2302.09612v2","created_at":"2026-07-05T06:46:00Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2302.09612","created_at":"2026-07-05T06:46:00Z"},{"alias_kind":"pith_short_12","alias_value":"MMCY6EBBOC5T","created_at":"2026-07-05T06:46:00Z"},{"alias_kind":"pith_short_16","alias_value":"MMCY6EBBOC5TMC3P","created_at":"2026-07-05T06:46:00Z"},{"alias_kind":"pith_short_8","alias_value":"MMCY6EBB","created_at":"2026-07-05T06:46:00Z"}],"graph_snapshots":[{"event_id":"sha256:d88403012f7cb9579a108cd77e6580ff7d86eee67584e8fa8c9e4a30afc9dc8c","target":"graph","created_at":"2026-07-05T06:46:00Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"integrity":{"available":true,"clean":true,"detectors_run":[],"endpoint":"/pith/2302.09612/integrity.json","findings":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"The conventional more-is-better dose selection paradigm, which targets the maximum tolerated dose (MTD), is not suitable for the development of targeted therapies and immunotherapies as the efficacy of these novel therapies may not increase with the dose. The U.S. Food and Drug Administration (FDA) has launched Project Optimus \"to reform the dose optimization and dose selection paradigm in oncology drug development\", and recently published a draft guidance on dose optimization, which outlines various approaches to achieve this goal. One highlighted approach involves conducting a randomized pha","authors_text":"Bo Huang, Daniel Li, Peng Yang, Ruitao Lin, Ying Yuan","cross_cats":["stat.AP"],"headline":"","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2023-02-19T16:16:33Z","title":"Design and Sample Size Determination for Multiple-dose Randomized Phase II Trials for Dose Optimization"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2302.09612","kind":"arxiv","version":2},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:76ab9c9ea6c3785c2b3d6df033b6577550bc00b90352e791e4916a4adf65453f","target":"record","created_at":"2026-07-05T06:46:00Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"7408f3f0fd3bfda391cb9e9d861c97242d01167706b9701e459a46ce8d4c6c8f","cross_cats_sorted":["stat.AP"],"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2023-02-19T16:16:33Z","title_canon_sha256":"c5c74875966c306a7687d5a2d6d226132b244da62a4ead993029a12e64e8804d"},"schema_version":"1.0","source":{"id":"2302.09612","kind":"arxiv","version":2}},"canonical_sha256":"63058f102170bb360b6f83f903b8ea3711c8f185c768d53476154a3713a44665","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"63058f102170bb360b6f83f903b8ea3711c8f185c768d53476154a3713a44665","first_computed_at":"2026-07-05T06:46:00.721425Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-07-05T06:46:00.721425Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"SyTREL2qX1Db0sYWAaSTfR0MqKKNH6AEngdqm+2lkYlKxGt4Pa/S+01mF5L0LYiWxE7aPX8BBRZBHMAe01+UBQ==","signature_status":"signed_v1","signed_at":"2026-07-05T06:46:00.721935Z","signed_message":"canonical_sha256_bytes"},"source_id":"2302.09612","source_kind":"arxiv","source_version":2}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:76ab9c9ea6c3785c2b3d6df033b6577550bc00b90352e791e4916a4adf65453f","sha256:d88403012f7cb9579a108cd77e6580ff7d86eee67584e8fa8c9e4a30afc9dc8c"],"state_sha256":"dad11c83b64a5f00fc22686fcd4b2f456b9b04f62e0b0b23f38a4573fee57d05"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"QcylN3bH35iFeCPISsDNhcaO+vnHXIxuRJzMnbtQ/sS4WYBidNycVAwIq8ey6rY5uke6MH81EiRnON+CetV6Bg==","signed_message":"bundle_sha256_bytes","signed_at":"2026-08-13T15:21:26.651815Z","bundle_sha256":"7e31f0f4b7b4df5e69b1149d0f0e9c4a62c0852bcd5125bd52cc9fd0a19c7111"}}